365 related articles for article (PubMed ID: 34239943)
1. An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics.
Chen PK; Chen DY
J Immunol Res; 2021; 2021():8998358. PubMed ID: 34239943
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-18: a biomarker with therapeutic potential in adult-onset Still's disease.
Chen PK; Wey SJ; Chen DY
Expert Rev Clin Immunol; 2022 Aug; 18(8):823-833. PubMed ID: 35771972
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
[TBL] [Abstract][Full Text] [Related]
4. Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease.
Hu Q; Shi H; Zeng T; Liu H; Su Y; Cheng X; Ye J; Yin Y; Liu M; Zheng H; Wu X; Chi H; Zhou Z; Jia J; Sun Y; Teng J; Yang C
Arthritis Res Ther; 2019 Jan; 21(1):9. PubMed ID: 30616678
[TBL] [Abstract][Full Text] [Related]
5. Adult-onset Still's disease.
Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
[TBL] [Abstract][Full Text] [Related]
6. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and management of adult-onset Still's disease.
Efthimiou P; Georgy S
Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
[TBL] [Abstract][Full Text] [Related]
10. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
[TBL] [Abstract][Full Text] [Related]
11. sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia.
Colafrancesco S; Priori R; Alessandri C; Astorri E; Perricone C; Blank M; Agmon-Levin N; Shoenfeld Y; Valesini G
Immunol Res; 2014 Dec; 60(2-3):177-83. PubMed ID: 25388964
[TBL] [Abstract][Full Text] [Related]
12. [Current concepts on the physiopathology of adult-onset Still's disease].
Arlet JB; Le Thi Huong DB; Pouchot J; Piette JC
Rev Med Interne; 2005 Jul; 26(7):549-56. PubMed ID: 15996569
[TBL] [Abstract][Full Text] [Related]
13. Activation mechanisms of monocytes/macrophages in adult-onset Still disease.
Tsuboi H; Segawa S; Yagishita M; Toko H; Honda F; Kitada A; Miki H; Ohyama A; Hagiwara S; Kondo Y; Matsumoto I; Sumida T
Front Immunol; 2022; 13():953730. PubMed ID: 36090971
[TBL] [Abstract][Full Text] [Related]
14. Pyroptosis: the potential eye of the storm in adult-onset Still's disease.
He X; You R; Shi Y; Zeng Z; Tang B; Yu J; Xiao Y; Xiao R
Inflammopharmacology; 2023 Oct; 31(5):2269-2282. PubMed ID: 37429997
[TBL] [Abstract][Full Text] [Related]
15. Increased serum vitamin B12 levels are associated with adult-onset Still's disease with reactive macrophage activation syndrome.
Kalyoncu U; Buyukasik Y; Akdogan A; Karadag O; Bilgen SA; Kiraz S; Ertenli I; Calguneri M
Joint Bone Spine; 2010 Mar; 77(2):131-4. PubMed ID: 20138793
[TBL] [Abstract][Full Text] [Related]
16. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
[TBL] [Abstract][Full Text] [Related]
17. Circulating Neutrophil Extracellular Traps Signature for Identifying Organ Involvement and Response to Glucocorticoid in Adult-Onset Still's Disease: A Machine Learning Study.
Jia J; Wang M; Ma Y; Teng J; Shi H; Liu H; Sun Y; Su Y; Meng J; Chi H; Chen X; Cheng X; Ye J; Liu T; Wang Z; Wan L; Zhou Z; Wang F; Yang C; Hu Q
Front Immunol; 2020; 11():563335. PubMed ID: 33240258
[TBL] [Abstract][Full Text] [Related]
18. Serum cytokine profiles in patients with adult onset Still's disease.
Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
[TBL] [Abstract][Full Text] [Related]
19. Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still's disease and their association with cytokines.
Yoshida S; Koga T; Fujita Y; Yatsuhashi H; Matsumoto H; Sumichika Y; Saito K; Sato S; Asano T; Kobayakawa M; Ohira H; Mizokami M; Sugiyama M; Migita K
Front Immunol; 2024; 15():1385654. PubMed ID: 38711500
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
